Iindaba zeNkampani
-
UGqirha Zhou Yingjun, u-CEO we-Geneham Pharmaceutical wenza intetho e-CPHI
Kuyaziwa ukuba i-CPHI China yenye yezona ndawo ziphambili zokurhweba kunye nokutshintshiselana ngeyona ndlela iphambili kuyo yonke imveliso yezamayeza eAsia, enika indawo enkulu kumashishini amaTshayina ukuya kumashishini aphesheya nokuphuhlisa intsebenziswano yamanye amazwe. A ...Funda ngokugqithisileyo -
Umnumzana Hu Jianjun, umlawuli wentengiso we-Geneham Pharmaceutical uzimase intlanganiso yokulungiselela intlanganiso yonyaka ye-12 ye-HNBEA
Nge-26th ka-Okthobha i-2020, uMnu Hu Jianjun- umlawuli wentengiso we-Geneham Pharmaceutical Co, Ltd, ilungu lebhunga le-HNBEA (Hunan Botanical Extracts Association) uzimase intlanganiso yokulungiselela intlanganiso yonyaka ye-12 ye-HNBEA. "Intlanganiso yonyaka ye-2021 HNBEA kunye neForum ye-12th Summit yeChina Plant ...Funda ngokugqithisileyo -
UGqirha Zhou Yingjun, u-CEO we-Geneham Pharmaceutical uthatha inxaxheba ekubhaleni iphepha elimhlophe lase-China kwizityalo ezikhutshiweyo
Ekuqaleni kwee-1980, iziphumo ebezingalindelekanga zeekhemikhali zabangela iliza elikhulu "lokukhuthaza nokubuyela kwindalo"; Kwi-1994, i-United States yapasisa umthetho "Umthetho weDiary Supplement Health and Education Act (DSHEA)", owawuseke ngokusesikweni ubume obusemthethweni bokukhutshwa kwesityalo njengempahla eluhlaza ...Funda ngokugqithisileyo
